- Home
- EWCZ vs AQST Comparison
EWCZ vs AQST Comparison
Compare EWCZ & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWCZ
- AQST
- Stock Information
- Founded
- EWCZ 2004
- AQST 2004
- Country
- EWCZ United States
- AQST United States
- Employees
- EWCZ N/A
- AQST N/A
- Industry
- EWCZ Package Goods/Cosmetics
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- EWCZ Consumer Discretionary
- AQST Health Care
- Exchange
- EWCZ Nasdaq
- AQST Nasdaq
- Market Cap
- EWCZ N/A
- AQST 274.4M
- IPO Year
- EWCZ 2021
- AQST 2018
- Fundamental
- Price
- EWCZ $3.97
- AQST $2.94
- Analyst Decision
- EWCZ Buy
- AQST Strong Buy
- Analyst Count
- EWCZ 7
- AQST 7
- Target Price
- EWCZ $6.07
- AQST $10.57
- AVG Volume (30 Days)
- EWCZ 745.2K
- AQST 1.4M
- Earning Date
- EWCZ 03-11-2025
- AQST 03-05-2025
- Dividend Yield
- EWCZ N/A
- AQST N/A
- EPS Growth
- EWCZ 29.60
- AQST N/A
- EPS
- EWCZ 0.22
- AQST N/A
- Revenue
- EWCZ $216,916,000.00
- AQST $57,561,000.00
- Revenue This Year
- EWCZ $5.65
- AQST N/A
- Revenue Next Year
- EWCZ $4.11
- AQST $39.51
- P/E Ratio
- EWCZ $17.72
- AQST N/A
- Revenue Growth
- EWCZ N/A
- AQST 13.79
- 52 Week Low
- EWCZ $2.72
- AQST $2.24
- 52 Week High
- EWCZ $13.15
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- EWCZ 29.51
- AQST 47.23
- Support Level
- EWCZ $3.83
- AQST $3.05
- Resistance Level
- EWCZ $4.33
- AQST $3.24
- Average True Range (ATR)
- EWCZ 0.25
- AQST 0.20
- MACD
- EWCZ 0.02
- AQST 0.02
- Stochastic Oscillator
- EWCZ 22.87
- AQST 36.18
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.